BindingDB logo
myBDB logout

27 articles for DuPont Merck Pharmaceutical Company


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDArticle TitlePublishedDeposition
9207948 Discovery of an orally active series of isoxazoline glycoprotein IIb/IIIa antagonists. 07-AUG-1997 04-NOV-2012
8576904 Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy. 08-MAR-1996 03-NOV-2012
7562922 Antiinflammatory 4,5-diarylpyrroles. 2. Activity as a function of cyclooxygenase-2 inhibition. 08-NOV-1995 30-OCT-2012
7905926 Piperidinyltetralin sigma ligands. 15-MAR-1994 28-OCT-2012
1356154 Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain. XX-XXX-1992 09-NOV-2011
9818151 Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitors. XX-OCT-1998 15-APR-2011
7932530 Heteroaryl-fused 2-phenylisothiazolone inhibitors of cartilage breakdown. 27-OCT-1994 10-NOV-2009
7636854 Balanced AT1/AT2 receptor antagonists. 4. XR510 and related 5-(3-amidopropanoyl)imidazoles possessing equal affinity for the AT1 and AT2 receptors. 12-SEP-1995 10-NOV-2009
9438022 Rational design and synthesis of novel, potent bis-phenylamidine carboxylate factor Xa inhibitors. 19-FEB-1998 10-NOV-2009
9016328 Discovery of potent isoxazoline glycoprotein IIb/IIIa receptor antagonists. 04-MAR-1997 10-NOV-2009
8863807 HIV protease inhibitory bis-benzamide cyclic ureas: a quantitative structure-activity relationship analysis. 25-NOV-1996 10-NOV-2009
9406598 Nonsymmetrically substituted cyclic urea HIV protease inhibitors. 08-JAN-1998 10-NOV-2009
9871548 The synthesis and evaluation of cyclic ureas as HIV protease inhibitors: modifications of the P1/P1' residues. 27-JAN-1999 10-NOV-2009
9871551 Structure-based design and synthesis of a series of hydroxamic acids with a quaternary-hydroxy group in P1 as inhibitors of matrix metalloproteinases. 27-JAN-1999 10-NOV-2009
9871540 Pyrazoles, 1,2,4-triazoles, and tetrazoles as surrogates for cis-amide bonds in boronate ester thrombin inhibitors. 27-JAN-1999 10-NOV-2009
9871528 Potent cyclic urea HIV protease inhibitors with 3-aminoindazole P2/P2' groups. 27-JAN-1999 10-NOV-2009
9871675 Structure-activity relationships (SAR) of some tetracyclic heterocycles related to the immunosuppressive agent Brequinar Sodium. 01-FEB-1999 10-NOV-2009
9873427 Heteroatom- and carbon-linked biphenyl analogs of Brequinar as immunosuppressive agents. 29-JAN-1999 10-NOV-2009
9871674 Rational design of boropeptide thrombin inhibitors: beta, beta-dialkyl-phenethylglycine P2 analogs of DuP 714 with greater selectivity over complement factor I and an improved safety profile. 01-FEB-1999 10-NOV-2009
9871711 The synthesis of symmetrical and unsymmetrical P1/P1' cyclic ureas as HIV protease inhibitors. 05-MAY-1998 09-JAN-2006
9154969 Improved P1/P1' substituents for cyclic urea based HIV-1 protease inhibitors: synthesis, structure-activity relationship, and X-ray crystal structure analysis. 09-MAY-1997 09-JAN-2006
8667359 Preparation and structure-activity relationship of novel P1/P1'-substituted cyclic urea-based human immunodeficiency virus type-1 protease inhibitors. 24-MAY-1996 09-JAN-2006
11354366 Quinazolines as cyclin dependent kinase inhibitors. 07-MAY-2001 23-DEC-2005
11311054 Indenopyrazoles as novel cyclin dependent kinase (CDK) inhibitors. 26-APR-2001 23-DEC-2005
9836627 Stereoisomers of cyclic urea HIV-1 protease inhibitors: synthesis and binding affinities. 03-DEC-1998 19-OCT-2004
9171880 Design, synthesis, and evaluation of tetrahydropyrimidinones as an example of a general approach to nonpeptide HIV protease inhibitors. 23-MAY-1997 21-SEP-2004
8784449 Cyclic HIV protease inhibitors: synthesis, conformational analysis, P2/P2' structure-activity relationship, and molecular recognition of cyclic ureas. 30-AUG-1996 18-OCT-2001